Add like
Add dislike
Add to saved papers

Effective control of sclerotinia stem rot in canola plants through application of exogenous hairpin RNA of multiple S. sclerotiorum genes.

Phytopathology 2024 March 21
Sclerotinia stem rot (SSR) is a globally destructive plant disease caused by Sclerotinia sclerotiorum . Current management of SSR primarily relies on chemical fungicides and crop rotation, raising environmental concerns. In this study, we developed an eco-friendly RNA bio-fungicide targeting S. sclerotiorum . Six S. sclerotiorum genes were selected for dsRNA synthesis. Four genes, including a Chitin binding domain (CBD), Mitogen-activated protein kinase (MAPK), oxaloacetate acetylhydrolase (OA), and Abhydrolase-3 (Abh), were combined to express hairpin RNA in E. coli HT115. Application of total RNA extracted from E. coli HT115 expressing hairpin RNA on disease progressive and necrosis lesion was evaluated. Gene expression analysis using real-time PCR showed silencing of the target genes using 50 ng/µl of dsRNA in a fungal liquid culture. Detached leaf assay and greenhouse application of dsRNA on canola stem and leaves showed variation in the reduction of necrosis symptoms by dsRNA of different genes, with Abhydrolase-3 being the most effective. The dsRNA from a combination of four genes reduced disease severity significantly (P = 0.01). Plants sprayed with hpRNA from four genes had lesions that were almost 30% smaller than that of plants treated with Abh alone, in lab and greenhouse assays. Results of this study highlight the potential of RNAi to manage diseases caused by S. sclerotiorum ; however, it also shows that additional research is necessary to optimize its efficacy.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app